Elevance's Medicaid Retreat: Exits Where "the Economics Don't Support Sustainable Performance"
New finding (2026-09-28): Elevance Health's state-by-state Medicaid withdrawal is accelerating — a second state exit landed in September 2026 (Louisiana, following Washington D.C. in August) — and the company's own guidance puts its 2026 Medicaid operating margin at negative 1.75%. This is the cleanest live demonstration of the topic's thesis: the government-program insurance book is where margins go to die, not where the money is.
The exits, in sequence
- Washington D.C. (effective Aug 1, 2026): Wellpoint DC exited D.C.'s Medicaid program by "mutual agreement" with the D.C. Department of Health Care Finance — a contract awarded in 2022 that was scheduled to run through January 2028, i.e., abandoned 17 months early. Elevance cut 85 D.C. jobs in the wind-down (KFF; Becker's).
- Louisiana (announced September 2026): the Louisiana Department of Health "announced that Elevance's Healthy Blue plan will exit the state's Medicaid program after its contract expires at the end of 2026," with 216 Louisiana jobs cut (KFF; Becker's).
- The forward signal: on its July 2026 earnings call, Elevance said it is reviewing the Medicaid portfolio and "will plan to exit markets 'where the economics don't support sustainable performance,'" with executives expecting exits "over the next 12 to 18 months" (KFF).
Why a top-3 Medicaid insurer is walking away from members
Elevance holds Medicaid MCO contracts in 21 states and 11% of national Medicaid MCO enrollment (Centene leads at 18%, then UNH 9%, Molina 7%, Aetna/CVS 3%) — the five for-profits together control nearly half the market (KFF). The economics it is fleeing, per its own disclosure: full-year 2026 Medicaid operating margin of -1.75%, with "incremental acuity pressure in 2027" expected. The market-wide backdrop from KFF's NAIC analysis: Medicaid managed care MLR rose from 88% (2023) to 91% (2024) — "the highest average MLR seen across health insurance markets… in 2024 and the highest average MLR observed for the Medicaid managed care market in the past decade." A 91% MLR leaves roughly nothing for admin and profit before the state's regulators even weigh in; the 2025 reconciliation law (work requirements, more frequent redeterminations, provider-tax and state-directed-payment caps) makes capitation-rate setting an actuarial guessing game, which is precisely when fixed-rate risk becomes unsignable.
The retreat is not unique to Elevance — Centene reportedly plans to exit Arkansas's Medicaid expansion in 2027 "citing current funding challenges" — but Elevance is the first large multi-state parent to make exits an explicit, repeated, guidance-level strategy (KFF). Note the contrast inside the same company: Elevance reaffirmed 2026 adjusted EPS guidance of at least $27 and beat Q2 estimates by 20% (/markets/ELV/2026/09/28) — the enterprise is fine because Carelon and the commercial book carry it while the Medicaid book bleeds. That's Elevance Health: Carelon and the Internal Profit Engine of Vertical Integration doing exactly what the vertical-integration thesis predicts.
What this means for the thesis
The popular narrative holds that insurers gorge on government programs; the filing-level reality is that Medicaid managed care is currently a negative-margin business for one of its largest players, who is exiting rather than cross-subsidizing indefinitely. The anger at insurers (rate-driven plan exits do disrupt care — KFF flags provider admin burden and continuity-of-care risk) is real, but the direction of the money is the opposite of the narrative: states are now the ones bidding to keep insurers in market, and Louisiana will "pay remaining plans more" after exits (newsfromthestates). Where the money actually is: the services arms (Carelon, Optum, Evernorth) and the MA bonus pool — see The Managed Care Profit Engine: Vertical Integration, Services, and the Regulated Margin Myth and Medicare Advantage Star Ratings: 2027 Release Repriced the Sector — Humana's Reversal, the Giants' Step-Down, Alignment's Suit Threat.